BACKGROUND: B7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are important regulators of T cell activation. We investigated the role of the B7 family of costimulatory molecules in the development of the systemic maternal immune tolerance during healthy pregnancy (HP). We also aimed to investigate the intracellular expression of indoleamine-2,3-dioxygenase (IDO) and plasma levels of tryptophane (TRP), kynurenine (KYN) and kynurenic acid (KYNA), important molecules with immunoregulatory properties, in order to describe their potential contribution to the pregnancy-specific maternal immune tolerance. METHODS: We determined the frequency of activated (CD11b+) monocytes expressing B7-1, B7-2, B7-H1, and B7-H2, an...
Indoleamine 2,3-dioxygenase (IDO) has been implicated in preventing the fetus from undergoing matern...
Immune checkpoint molecules, like CTLA-4, TIM-3, PD-1, are negative regulators of immune responses t...
Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) catalyze the rate-limiting...
BACKGROUND: B7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are impo...
PROBLEM: We determined the frequency of activated (CD11b+) monocytes expressing B7-1, B7-2, B7-H1, a...
Alterations in the expression of B7 costimulatory molecules and their receptors, as well as differe...
During pregnancy, the mother allows the immunologically distinct fetoplacental unit to develop and g...
B7 costimulation and intracellular indoleamine-2, 3-dioxygenase (IDO) expression in peripheral blood...
Nonclassical human leukocyte antigen (HLA) class I molecule HLA-G and indoleamine 2,3 dioxygenase (...
AbstractAlterations in the expression of B7 costimulatory molecules and their receptors, as well as ...
In a successful pregnancy, the semiallogeneic fetus is not rejected by the maternal immune system, w...
During pregnancy, the maternal immune system protects the allogeneic foetus from rejection. At the s...
Abstract Problem: The T-cell immunoglobulin and mucin domain (TIM) family is a relatively newly des...
Indoleamine 2,3 – dioxygenase (IDO) is an enzyme that aids in immunosuppression and tolerance. Prev...
In a successful pregnancy, the semiallogeneic fetus is not rejected by the maternal immune system, w...
Indoleamine 2,3-dioxygenase (IDO) has been implicated in preventing the fetus from undergoing matern...
Immune checkpoint molecules, like CTLA-4, TIM-3, PD-1, are negative regulators of immune responses t...
Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) catalyze the rate-limiting...
BACKGROUND: B7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are impo...
PROBLEM: We determined the frequency of activated (CD11b+) monocytes expressing B7-1, B7-2, B7-H1, a...
Alterations in the expression of B7 costimulatory molecules and their receptors, as well as differe...
During pregnancy, the mother allows the immunologically distinct fetoplacental unit to develop and g...
B7 costimulation and intracellular indoleamine-2, 3-dioxygenase (IDO) expression in peripheral blood...
Nonclassical human leukocyte antigen (HLA) class I molecule HLA-G and indoleamine 2,3 dioxygenase (...
AbstractAlterations in the expression of B7 costimulatory molecules and their receptors, as well as ...
In a successful pregnancy, the semiallogeneic fetus is not rejected by the maternal immune system, w...
During pregnancy, the maternal immune system protects the allogeneic foetus from rejection. At the s...
Abstract Problem: The T-cell immunoglobulin and mucin domain (TIM) family is a relatively newly des...
Indoleamine 2,3 – dioxygenase (IDO) is an enzyme that aids in immunosuppression and tolerance. Prev...
In a successful pregnancy, the semiallogeneic fetus is not rejected by the maternal immune system, w...
Indoleamine 2,3-dioxygenase (IDO) has been implicated in preventing the fetus from undergoing matern...
Immune checkpoint molecules, like CTLA-4, TIM-3, PD-1, are negative regulators of immune responses t...
Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO) catalyze the rate-limiting...